about
A short history of voltage-gated calcium channelsPharmacological Approaches for Treatment-resistant Bipolar DisorderGenetic disruption of voltage-gated calcium channels in psychiatric and neurological disordersThe mechanism of action of calcium antagonists on arrhythmias in early myocardial ischaemia: studies with nifedipine and DHM9Characterization of dihydropyridine-sensitive calcium channels in rat brain synaptosomesVerapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation.Alteration of the [Ca(2+)](i)-force relationship during the vasorelaxation induced by a Ca(2+) channel blocker SR33805 in the porcine coronary artery.Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure.Phenotypic screens as a renewed approach for drug discovery.Effects of intravenous diltiazem in a rat model of experimental coronary thrombotic microembolism.Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channelTetrodotoxin as a tool to elucidate sensory transduction mechanisms: the case for the arterial chemoreceptors of the carotid body.Integrating subpathway analysis to identify candidate agents for hepatocellular carcinoma.Calcium Signaling and Cardiac Arrhythmias.Dotarizine versus flunarizine as calcium antagonists in chromaffin cells.Voltage-gated calcium channels - from basic mechanisms to disease.Voltage-gated calcium channels: their discovery, function and importance as drug targetsWithdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty
P2860
Q24670360-BF974CFB-8528-46A3-9B0D-6E2AE0C33F12Q26783002-6FD594A6-9BF8-42A2-AFAF-5559F353F975Q26783154-F3F4FABA-4C62-48C2-AE66-303552154F98Q28361211-AC8233A8-2BBC-4B7F-8D6E-97923E60049FQ33653019-304AE030-51FC-45FC-9E3B-96E5045CD566Q34459263-EC5ADB25-FC69-4FDF-8BC3-DEB9FE72446BQ35042997-1F55EDBE-B20E-4315-979B-553CB7181978Q35170482-A4E3B87D-CE45-4CDC-B3E6-23DB344E542EQ35936197-982CD17A-1F9B-4BCC-8D95-21BC4CB086D1Q37231298-26981DAB-2C1B-4447-983D-5390E865373BQ37362037-04AC9EB0-D19E-42C8-BCBB-5227C0ADCBA2Q37849476-72FF2D0F-CA69-43D0-80DE-7429B93263D8Q37987914-EB82CB3F-0C4D-47C1-917B-ADBE00AB38F1Q38944703-52C0ACEF-AAC3-4389-AF47-AC2F98A6505CQ39360546-4E241B1C-8214-49A2-82AF-905671D78E71Q42369535-1AD3F798-5927-4DB4-8D8A-D4345B4981A0Q42383201-F862DEA9-C3A0-4274-9B11-7C67819191C2Q57484915-376CD0AE-4E22-4C33-BA5A-7C3644C41478Q58572183-9C4EA625-BA50-4101-BC33-C87476C0AF94
P2860
description
1983 nî lūn-bûn
@nan
1983 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
History of calcium antagonists.
@ast
History of calcium antagonists.
@en
History of calcium antagonists.
@nl
type
label
History of calcium antagonists.
@ast
History of calcium antagonists.
@en
History of calcium antagonists.
@nl
prefLabel
History of calcium antagonists.
@ast
History of calcium antagonists.
@en
History of calcium antagonists.
@nl
P1433
P1476
History of calcium antagonists.
@en
P2093
Fleckenstein A
P433
P577
1983-02-01T00:00:00Z